Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Clinical trial NCT02943668 · TERMINATED
Trial details
- NCT number
- NCT02943668
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2018-12-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.